United States Somatostatin Market: Key Trends and Emerging Opportunities by 2034
North America is the leading region in the somatostatin market, with the US contributing the largest share and Canada providing steady additional demand. Analogs such as octreotide, lanreotide, and pasireotide are widely prescribed for acromegaly, neuroendocrine tumors (NETs), carcinoid syndrome, and Cushing’s disease, backed by robust reimbursement, easy access to specialists, and high...
0 Commenti 0 condivisioni 3 Views 0 Anteprima